Senior insider sale
SVP, General Counsel at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$6.25M
12.96K shares
What this filing means
LIU JOY plans to sell 12.96K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $6.25M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001959173-26-001733
Officer· SVP, General Counsel
Since Mar 2021
12.96K
Shares to sell
$6.25M
Approx. market value
892.00
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/10/2025
892.00Total acquired892.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | Restricted Stock Vesting Compensation | 892.00 | — |
| Total | 892.00 | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.32K
Market value
$4.56M
2/13/2026
—Completed
Units to sell
812.00
Market value
$375.3K
2/12/2026
—Completed
Units to sell
1.39K
Market value
$621.6K
1/5/2026
—Completed
Units to sell
552.00
Market value
$255.6K
12/29/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
892.00
Market value
$442.4K
3/2/2026
Total
Units
12.96K
Value
$6.25M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/13/2026 | 9.32K | $4.56M | — | Completed |
2/12/2026 | 812.00 | $375.3K | — | Completed |
1/5/2026 | 1.39K | $621.6K | — | Completed |
12/29/2025 | 552.00 | $255.6K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 892.00 | $442.4K | NASDAQ | Planned |
| Total | 12.96K | $6.25M | ||